Synthetic Peptides Elicit Humoral Response against Porcine Reproductive and Respiratory Syndrome Virus in Swine
Authors:
- Francisco Perez-DuranFPFrancisco Perez-Duran
- Fernando Calderon-RicoFCFernando Calderon-Rico
- Luis Enrique Franco-CorreaLFLuis Enrique Franco-Correa
- Alicia Gabriela Zamora-AvilesAZAlicia Gabriela Zamora-Aviles
- Roberto Ortega-FloresRORoberto Ortega-Flores
- Daniel Durand-HerreraDDDaniel Durand-Herrera
- Alejandro Bravo-PatiñoABAlejandro Bravo-Patiño
- Ricarda Cortes-VieyraRicarda Cortes-Vieyra
- Ilane Hernandez-MoralesIHIlane Hernandez-Morales
- Rosa Elvira Nuñez-AnitaRosa Elvira Nuñez-Anita
Open Access
Abstract
The aim of this study was to analyze the immunogenic response elicited in swine by two synthetic peptides derived from GP5 to understand the role of lineal B epitopes in the humoral and B-cell-mediated response against the porcine reproductive and respiratory syndrome virus (PRRSV). For inoculation, twenty-one-day-old pigs were allocated into six groups: control, vehicle, vaccinated (Ingelvac-PRRSV, MLV®), non-vaccinated and naturally infected, GP5-B and GP5-B3. At 2 days post-immunization (dpi), the GP5-B3 peptide increased the serum concentrations of cytokines associated with activate adaptive cellular immunity, IL-1β (1.15 ± 1.15 to 10.17 ± 0.94 pg/mL) and IL-12 (323.8 ± 23.3 to 778.5 ± 58.11 pg/mL), compared to the control group. The concentration of IgGs anti-GP5-B increased in both cases at 21 and 42 dpi compared to that at 0 days (128.3 ± 8.34 ng/mL to 231.9 ± 17.82 and 331 ± 14.86 ng/mL), while IgGs anti-GP5-B3 increased at 21 dpi (105.1 ± 19.06 to 178 ± 15.09 ng/mL) and remained at the same level until 42 dpi. Also, antibody-forming/Plasma B cells (CD2+/CD21−) increased in both cases (9.85 ± 0.7% to 13.67 ± 0.44 for GP5-B and 15.72 ± 1.27% for GP5-B3). Furthermore, primed B cells (CD2−/CD21+) from immunized pigs showed an increase in both cases (9.62 ± 1.5% to 24.51 ± 1.3 for GP5-B and 34 ± 2.39% for GP5-B3) at 42 dpi. Conversely the naïve B cells from immunized pigs decreased compared with the control group (8.84 ± 0.63% to 6.25 ± 0.66 for GP5-B and 5.78 ± 0.48% for GP5-B3). Importantly, both GP5-B and GP5-B3 peptides exhibited immunoreactivity against serum antibodies from the vaccinated group, as well as the non-vaccinated and naturally infected group. In conclusion, GP5-B and GP5-B3 peptides elicited immunogenicity mediated by antigen-specific IgGs and B cell activation.Keywords
All Related Versions
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (A1-S-43236, INFR-2015-01 255010, FCCHTI23_ME-4.1.-0014, 317189)
- CIC-UMSNH (A1-S-43236, INFR-2015-01 255010, FCCHTI23_ME-4.1.-0014, 317189)
- PAPPIT-UNAM IA208322 (A1-S-43236, INFR-2015-01 255010, FCCHTI23_ME-4.1.-0014, 317189)
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (A1-S-43236, INFR-2015-01 255010, FCCHTI23_ME-4.1.-0014, 317189)
- ICTI Michoacan (A1-S-43236, INFR-2015-01 255010, FCCHTI23_ME-4.1.-0014, 317189)
- CONAHCYT, “FOMENTO A LA INFRAESTRUCTURA CIENTÍFICA” 2021 (A1-S-43236, INFR-2015-01 255010, FCCHTI23_ME-4.1.-0014, 317189)
This publication has 68 references indexed in Scilit:
- Infection dynamics and incidence of wild-type porcine reproductive and respiratory syndrome virus in growing pig herds in the U.S. MidwestPreventive Veterinary Medicine, 2023
- Antiviral Strategies against PRRSV InfectionTrends in Microbiology, 2017
- Generation of porcine reproductive and respiratory syndrome (PRRS) virus-like-particles (VLPs) with different protein compositionJournal of Virological Methods, 2016
- The global research trend of porcine reproductive and respiratory syndrome virus (PRRSV): A mini reviewToxicology and Environmental Health Sciences, 2015
- Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future directionVaccine, 2015
- Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virusJournal of Virological Methods, 2014
- Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunityVaccine, 2013
- Characterization of antigenic regions in the porcine reproductive and respiratory syndrome virus by the use of peptide-specific serum antibodiesVaccine, 2011
- Identification of immunodominant T-cell epitopes present in glycoprotein 5 of the North American genotype of porcine reproductive and respiratory syndrome virusVaccine, 2008
- A recombinant plasmid co-expressing swine ubiquitin and the GP5 encoding-gene of porcine reproductive and respiratory syndrome virus induces protective immunity in pigletsVaccine, 2008